Drugs News and Research

RSS

First Edition: October 8, 2012

Today's headlines include reports and analysis from the campaign trail regarding both the presidential contest as well as House and Senate races.

8 Oct 2012

Functional profiling using EVA/PCD doubles response rate and improves survival in NSCLC patients

Functional profiling using ex-vivo analysis of programmed cell death (EVA/PCD) doubles the response rate and improves time-to-progression and survival in patients with advanced lung cancer, according to a Phase II clinical trial conducted by investigators at Rational Therapeutics and the MemorialCare Todd Cancer Institute and published in the October issue of Anticancer Research.

8 Oct 2012

Researchers discover new group of nerve cells that regulate processes of learning and memory

Swedish researchers at Uppsala University have, together with Brazilian collaborators, discovered a new group of nerve cells that regulate processes of learning and memory. These cells act as gatekeepers and carry a receptor for nicotine, which can explain our ability to remember and sort information.

8 Oct 2012

Anesthetics and protein interactions: an interview with José A. Fernández

For a long time there was a controversy about how anesthetics work. The large number of molecules that have anesthetic properties (from benzodiazepines to nitrous oxide) and their very different structures...

8 Oct 2012

Researchers discover smallest and fastest-known RNA switches

A University of Michigan biophysical chemist and his colleagues have discovered the smallest and fastest-known molecular switches made of RNA, the chemical cousin of DNA. The researchers say these rare, fleeting structures are prime targets for the development of new antiviral and antibiotic drugs.

8 Oct 2012

Kaneka to launch new Protein A Chromatography Resin for purification of therapeutic antibodies

Kaneka Corporation on 19/09/2012, announces the launch of KANEKA KanCapA, a new Protein A Chromatography Resin for the purification of therapeutic antibodies.

8 Oct 2012

Translational Genomics Research Institute creates new center for rare childhood disorders

The Translational Genomics Research Institute (TGen) today announced the creation of a new center that could have life changing effects on the lives of potentially thousands of children and their families.

6 Oct 2012

Research roundup: Limited savings found from ACOs; Examining men's health racial disparities

A Simulation Shows Limited Savings From Meeting Quality Targets Under The Medicare Shared Savings Program -- The health law rewards accountable care organizations (ACOs), groups of health care providers working together to save money and increase quality. Those providers then share in the savings.

6 Oct 2012

NIH awards $2.1M grant to study possible ways to fight cancer

A professor with the University of Houston Cullen College of Engineering has won a $2.1 million grant to study the best ways to modify human immune cells to fight against cancer.

6 Oct 2012

Researchers from three trials join to collaborate under European Dementia Prevention Initiative

Worldwide, the number of people with Alzheimer's disease will hit 115 million by 2050, according to the World Health Organization. Scientists, health officials, policymakers, and the public are asking if anything can slow down the disease.

6 Oct 2012

Opiate substitution therapies linked to reduced risk of HIV transmission

Methadone reduces the risk of HIV transmission in people who inject drugs (PWID), as reported by an international team of researchers in a paper published today in the online edition of the British Medical Journal. This team included Dr. Julie Bruneau from the CHUM Research Centre (CRCHUM) and the Department of Family Medicine at the Universit- de Montr-al.

6 Oct 2012

BUSM leads genome-wide evaluation of genetic variants associated with Parkinson's disease

Boston University School of Medicine investigators have led the first genome-wide evaluation of genetic variants associated with Parkinson's disease (PD). The study, which is published online in PLOS ONE, points to the involvement of specific genes and alterations in their expression as influencing the risk for developing PD.

6 Oct 2012

Researchers discover brain mechanism responsible for sensation of nausea

Nausea is a common and distressing side effect of many drugs and treatments. Unlike vomiting, nausea is not well understood, but new research by University of Guelph scientists may soon change that.

6 Oct 2012

Nanoprobe inventor awarded NJIT Board of Overseers Excellence in Research Prize and Medal

NJIT Research Professor Reginald C. Farrow, PhD, who with his research team have discovered how to make nanoscale arrays of the world's smallest probe for investigating the electrical properties of individual living cells was awarded yesterday, Oct. 4, 2012, the NJIT Board of Overseers Excellence in Research Prize and Medal. This prize is the most prestigious research award at NJIT. It is the fifth time the award has been made.

6 Oct 2012

Combination pill to treat malaria pre-approved by WHO

"A malaria drug made by India's Cipla has been pre-qualified by the World Health Organization (WHO), an important step towards its roll-out across Asia, where millions of people are infected with the mosquito-borne disease every year," Reuters reports.

6 Oct 2012

Two genes linked to increased risk of diabetes-associated kidney disease

An international group of researchers has discovered two genes that increase the risk of developing diabetes-associated kidney disease.

6 Oct 2012

91 charged with $430 million Medicare billing fraud

The nationwide sweep involved arrests of doctors, nurses and other licensed medical professionals.

6 Oct 2012

Authorities shut down 18K online pharmacy sites in crackdown of fake drug sales

"Police and regulators around the world have closed 18,000 online pharmacy sites in the past few days, in the largest ever clampdown on criminal gangs selling unauthorized medicines online," the Financial Times reports.

6 Oct 2012

DPP-inhibitors reduce cardiovascular events in diabetes patients

Type 2 diabetes patients who are treated with dipeptidyl peptidase-4 inhibitors have a significantly reduced risk for cardiovascular events, particularly myocardial infarction, compared with their peers who take placebo or other drugs, results of a meta-analysis show.

5 Oct 2012

HIV transmission can be reduced by using opioid substitution treatments instead of injection drug use

People who inject drugs (PWID) can significantly reduce their risk of HIV infection with the use of opiate substitution treatments such as methadone, as suggested by an international team of researchers in a paper published today on bmj.com.

5 Oct 2012

Drugs News and Research

First Edition: October 8, 2012

Functional profiling using EVA/PCD doubles response rate and improves survival in NSCLC patients

Researchers discover new group of nerve cells that regulate processes of learning and memory

Anesthetics and protein interactions: an interview with José A. Fernández

Researchers discover smallest and fastest-known RNA switches

Kaneka to launch new Protein A Chromatography Resin for purification of therapeutic antibodies

Translational Genomics Research Institute creates new center for rare childhood disorders

Research roundup: Limited savings found from ACOs; Examining men's health racial disparities

NIH awards $2.1M grant to study possible ways to fight cancer

Researchers from three trials join to collaborate under European Dementia Prevention Initiative

Opiate substitution therapies linked to reduced risk of HIV transmission

BUSM leads genome-wide evaluation of genetic variants associated with Parkinson's disease

Researchers discover brain mechanism responsible for sensation of nausea

Nanoprobe inventor awarded NJIT Board of Overseers Excellence in Research Prize and Medal

Combination pill to treat malaria pre-approved by WHO

Two genes linked to increased risk of diabetes-associated kidney disease

91 charged with $430 million Medicare billing fraud

Authorities shut down 18K online pharmacy sites in crackdown of fake drug sales

DPP-inhibitors reduce cardiovascular events in diabetes patients

HIV transmission can be reduced by using opioid substitution treatments instead of injection drug use

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News